Berikutnya

Putar otomatis

HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches

0 Tampilan • 07/03/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis